Browsing Tag
Scott Schaffner
2 posts
SN share price firms as Smith+Nephew launches $500m buyback and Cevian Capital adds to 5% activist stake
Cevian wants a breakup. Deepak Nath wants RISE to deliver. The $500m buyback is the bridge. H2 2026 is where the real test of the Smith+Nephew thesis lands.
Smith+Nephew wraps up $330m acquisition of CartiHeal to expand sports medicine reach
Smith+Nephew, a global leader in medical technology, has officially completed the acquisition of CartiHeal, the developer of Agili-C,…